Loading...
XSHE002817
Market cap258mUSD
Dec 25, Last price  
6.30CNY
1D
-2.33%
1Q
12.30%
Jan 2017
-61.84%
IPO
-1.13%
Name

Anhui Huangshan Capsule Co Ltd

Chart & Performance

D1W1MN
XSHE:002817 chart
P/E
29.05
P/S
4.07
EPS
0.22
Div Yield, %
0.96%
Shrs. gr., 5y
-0.53%
Rev. gr., 5y
9.44%
Revenues
463m
+8.04%
189,446,728244,009,476268,953,187273,413,371253,790,897283,435,099285,955,869294,709,587325,557,296319,426,287379,891,008428,318,791462,771,215
Net income
65m
+6.60%
37,344,84847,936,67847,983,29851,761,10554,890,45852,284,78146,420,39035,966,20839,130,70245,255,71056,887,81160,850,37264,863,467
CFO
100m
+20.28%
22,936,30065,695,80023,126,72552,066,50540,324,01732,526,93844,423,82427,523,87952,028,24362,711,55786,089,40683,016,82099,856,436
Dividend
Jun 27, 20240.085 CNY/sh
Earnings
May 16, 2025

Profile

Anhui Huangshan Capsule Co., Ltd. manufactures and sells hollow and enteric hollow capsules in China. It offers entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colon soluble vacant gelatin capsules, hydroxypropyl methyl cellulose and hydroxypropyl starch hollow capsules, and pulluan capsules. The company was founded in 1989 and is based in Xuancheng, China.
URL
http://www.hsjn.com/
IPO date
Oct 25, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
462,771
8.04%
428,319
12.75%
379,891
18.93%
Cost of revenue
376,323
360,282
310,939
Unusual Expense (Income)
NOPBT
86,449
68,036
68,952
NOPBT Margin
18.68%
15.88%
18.15%
Operating Taxes
6,832
6,291
Tax Rate
7.90%
9.12%
NOPAT
79,617
68,036
62,661
Net income
64,863
6.60%
60,850
6.97%
56,888
25.70%
Dividends
(18,037)
(17,091)
(8,840)
Dividend yield
0.70%
0.64%
0.34%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,912
274
3,046
Long-term debt
10,221
274
72,782
Deferred revenue
30,095
31,203
25,610
Other long-term liabilities
1
1
Net debt
(233,477)
(370,094)
(333,601)
Cash flow
Cash from operating activities
99,856
83,017
86,089
CAPEX
(6,582)
Cash from investing activities
(208,066)
Cash from financing activities
(7,106)
47,756
FCF
105,578
58,321
25,470
Balance
Cash
243,759
370,641
409,429
Long term investments
1,851
Excess cash
222,471
349,225
390,435
Stockholders' equity
752,004
769,063
639,371
Invested Capital
720,560
527,744
515,399
ROIC
12.76%
13.04%
12.67%
ROCE
9.12%
7.71%
7.61%
EV
Common stock shares outstanding
294,834
299,098
299,098
Price
8.76
-2.23%
8.96
4.01%
8.61
31.78%
Market cap
2,582,745
-3.63%
2,679,920
4.01%
2,576,517
31.78%
EV
2,349,905
2,310,278
2,243,196
EBITDA
132,330
111,108
102,444
EV/EBITDA
17.76
20.79
21.90
Interest
24
2,047
185
Interest/NOPBT
0.03%
3.01%
0.27%